ArticleDevelopmental biology2026
Targeting the melanocytes of the inner ear: A comparison of different CreER lines.
Article in Developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The inner ear is responsible for hearing and balance. During development, the inner ear undergoes extensive morphogenesis to create a coil shaped cochlea and three semicircular canals from an original flat otic placode. During this morphogenesis, neural crest cells migrate into the inner ear in formation to become either glial cells or melanocytes. The glial cells are located in the cochleo-vestibular ganglion and the melanocytes reside in the stria vascularis in the cochlea and dark cells zone in the vestibule. The stria vascularis pumps potassium ions into the scala media, generating a positive endocochlear potential which is crucial to the mechanosensory cells for auditory signal transduction. Any defect in strial cells leads to the dysregulation of ionic composition of the endolymph, ultimately resulting in deafness. Despite this, we still do not know exactly how the stria vascularis develops and functions. To date, there is an absence of Cre driver mouse lines that effectively facilitate the study of individual cell development and functions within the stria vascularis, limiting our ability to understand strial deafness. Furthermore, the use of CreER transgenic mice lines introduces the possibility of poor recombination and non-specific expression. Therefore, it is necessary to establish a mouse line targeting each cell type within the stria vascularis. The present study aims to determine the most appropriate CreER transgenic line targeting the melanocytes of the inner ear by comparing three CreER mouse lines related to melanocyte development: Pax3, Dct, and Tyr. The CreER mice were crossed with tdTomato reporter mice and induced with tamoxifen at three time points E11.5, P0, and P28 to study the spatiotemporal recombination in the inner ear. We quantify the recombination efficiency in the intermediate cells at each time point and identify important variations in both efficiency and specificity for the three lines. This study focusing on cochlear and vestibular melanocytes provides a much-needed tool to study melanocyte development and function in the inner ear with spatiotemporal control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.